{"entity":{"type":"insider","cik":"0001648920","url":"/insider/0001648920","json_url":"/insider/0001648920.json","name":"Rozenman Mary M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":10,"first":"2016-09-09","last":"2018-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Rozenman Mary M.","source":"filing","n_filings":10,"first_seen":"2016-09-09","last_seen":"2018-03-05"}],"transactions":[{"id":6510575,"accession":"0000899243-18-006330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-006330","line_url":"/filing/0000899243-18-006330#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1807.0,"shares_display":"1,807","price_per_share":33.1,"price_display":"33.10","price_state":"stated","total_value":59811.7,"total_display":"59,811.70","total_whole":"59,812","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider"},{"id":6489197,"accession":"0000899243-18-002882","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-002882","line_url":"/filing/0000899243-18-002882","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6592.0,"shares_display":"6,592","price_per_share":35.3592114684466,"price_display":"35.36","price_state":"stated","total_value":233087.922,"total_display":"233,087.92","total_whole":"233,088","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider","n_lines":2},{"id":6130571,"accession":"0000899243-18-000456","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-000456","line_url":"/filing/0000899243-18-000456","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6591.0,"shares_display":"6,591","price_per_share":37.10971527840995,"price_display":"37.11","price_state":"stated","total_value":244590.1334,"total_display":"244,590.13","total_whole":"244,590","shares_owned_after":1730.0,"shares_owned_after_display":"1,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider","n_lines":2},{"id":5283319,"accession":"0000899243-17-029679","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000899243-17-029679","line_url":"/filing/0000899243-17-029679","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75010.0,"shares_display":"75,010","price_per_share":38.87596315157979,"price_display":"38.88","price_state":"stated","total_value":2916085.996,"total_display":"2,916,086.00","total_whole":"2,916,086","shares_owned_after":39139.0,"shares_owned_after_display":"39,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider","n_lines":14},{"id":4104385,"accession":"0000899243-17-021814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-021814","line_url":"/filing/0000899243-17-021814#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":675000.0,"total_display":"675,000.00","total_whole":"675,000","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-11","scope":"insider"},{"id":5237342,"accession":"0000899243-17-018322","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-17-018322","line_url":"/filing/0000899243-17-018322#line-6","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":21.38,"price_display":"21.38","price_state":"stated","total_value":6414.0,"total_display":"6,414.00","total_whole":"6,414","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-17","filed_date":"2017-07-17","scope":"insider"},{"id":5237337,"accession":"0000899243-17-018322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-018322","line_url":"/filing/0000899243-17-018322#line-4","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5666.0,"shares_display":"5,666","price_per_share":21.3863,"price_display":"21.39","price_state":"stated","total_value":121174.7758,"total_display":"121,174.78","total_whole":"121,175","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-14","filed_date":"2017-07-17","scope":"insider"},{"id":5237329,"accession":"0000899243-17-018322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-018322","line_url":"/filing/0000899243-17-018322#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8974.0,"shares_display":"8,974","price_per_share":21.4685,"price_display":"21.47","price_state":"stated","total_value":192658.319,"total_display":"192,658.32","total_whole":"192,658","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-13","filed_date":"2017-07-17","scope":"insider"},{"id":5009851,"accession":"0000899243-17-017973","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-017973","line_url":"/filing/0000899243-17-017973#line-4","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15060.0,"shares_display":"15,060","price_per_share":21.3952,"price_display":"21.40","price_state":"stated","total_value":322211.712,"total_display":"322,211.71","total_whole":"322,212","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"},{"id":5009840,"accession":"0000899243-17-017973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-017973","line_url":"/filing/0000899243-17-017973#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.5726,"price_display":"20.57","price_state":"stated","total_value":617178.0,"total_display":"617,178.00","total_whole":"617,178","shares_owned_after":129.0,"shares_owned_after_display":"129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-06","scope":"insider"},{"id":3312128,"accession":"0000899243-16-032770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-032770","line_url":"/filing/0000899243-16-032770#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24096.0,"shares_display":"24,096","price_per_share":17.6,"price_display":"17.60","price_state":"stated","total_value":424089.6,"total_display":"424,089.60","total_whole":"424,090","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-04","filed_date":"2016-11-04","scope":"insider"},{"id":2079629,"accession":"0000899243-16-031446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-031446","line_url":"/filing/0000899243-16-031446#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-05","filed_date":"2016-10-07","scope":"insider"},{"id":2772405,"accession":"0000899243-16-028746","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-028746","line_url":"/filing/0000899243-16-028746#line-2","is_derivative":false,"issuer_cik":"0001631650","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001631650","owner_cik":"0001648920","owner_name":"Rozenman Mary M.","owner_display_name":"Rozenman Mary M.","owner_url":"/insider/0001648920","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":504000.0,"total_display":"504,000.00","total_whole":"504,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-08","filed_date":"2016-09-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Officer","n_filings":10,"first_seen":"2016-09-09","last_seen":"2018-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001648920","retrieved_at":"2026-08-24T12:36:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}